Indocyanine green dye enhanced laser photocoagulation for juxtafoveal choroidal neovascularisation.

Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print Cited Medium: Print ISSN: 0301-4738 (Print) Linking ISSN: 03014738 NLM ISO Abbreviation: Indian J Ophthalmol Subsets: MEDLINE

Publication: Mumbai : Medknow Publications
Original Publication: Bombay : All-India Ophthalmological Society

Coloring Agents* ; Indocyanine Green*; Choroidal Neovascularization/*surgery ; Fovea Centralis/*surgery ; Laser Coagulation/*methods; Aged ; Aged, 80 and over ; Choroidal Neovascularization/pathology ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Fovea Centralis/pathology ; Fundus Oculi ; Humans ; Male ; Middle Aged ; Pilot Projects ; Retrospective Studies ; Treatment Outcome

Purpose: To evaluate the initial results of pilot study of indocyanine green dye enhanced laser photocoagulation for juxtafoveal choroidal neovascularisation (CNV).
Materials and Methods: The study was conducted on eleven eyes of 11 patients of CNV during the period 2001 and 2002. Two to three minutes after the injection of 5 ml of 25 mgm of indocyanine green (ICG) dye, 810 nm diode laser was used to treat the choroidal neovascular lesions.
Results: The age of the patients ranged from 45 to 80 years. All patients completed 12 months of follow-up. Eight eyes (72.7%) had neovascular age related macular degeneration, 2 eyes (18.2%) had myopic CNV and one eye (9.09%) had CNV secondary to angioid streak. The presenting visual acuity was or=6/12 in three patients. The final visual acuity at the end of at least 12 months follow-up was 6/12 or better in one eye (9%); 6/18-6/36 in 3 eyes (27.27%) and Conclusion: ICG dye enhanced diode laser photocoagulation appears to be a potential option for juxtafoveal CNV.

0 (Coloring Agents)
IX6J1063HV (Indocyanine Green)

Date Created: 20050903 Date Completed: 20060307 Latest Revision: 20190608

20240829

10.4103/0301-4738.16677

16137963